BiotechTube
Home/Q32 Bio/Shelia Violette, Ph.D.
SV

Shelia Violette, Ph.D.

Founder, Chief Scientific Officer & President of Research

Q32 Bio

Therapeutic Areas

Autoimmune DiseasesInflammatory Diseases

Q32 Bio Pipeline

DrugIndicationPhase
Bempikibart (ADX-914)Alopecia AreataPhase 2a
ADX-096Complement-Mediated DiseasesPreclinical
C3d mAb fusions & nanobodiesComplement-Mediated DiseasesDiscovery

Leadership Team at Q32 Bio

JM
Jodie Morrison
Chief Executive Officer
LK
Lee Kalowski, M.B.A.
President & Chief Financial Officer
View full Q32 Bio profile